Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Jaya Konstruksi Manggala Pratama Tbk (JKON) vs Merck Tbk. (MERK) Price & Performance

Jaya Konstruksi Manggala Pratama TbkTrade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Jaya Konstruksi Manggala Pratama Tbk vs Merck Tbk. — how do they compare? Jaya Konstruksi Manggala Pratama Tbk trades at Rp69 (market cap 1.09T, 1.3M 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Merck Tbk. is the larger of the two by market cap, and Jaya Konstruksi Manggala Pratama Tbk is more actively traded (1.3M versus 37.6K). Which is the better fit depends on your goals.

JKONMERK
Market Cap
1.09T1.7T
Volume
1.3M37.6K
Lot
13.01K376
Turnover
88.78M144.47M
Average Price
68.243,842.23
Value
88.78M144.47M
Indicative Equilibrium Price
693,840
Indicative Equilibrium Volume
1.9K7

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

JKON
View details
MERK
View details

About Jaya Konstruksi Manggala Pratama Tbk

PT Jaya Konstruksi Manggala Pratama Tbk (the company) was established dated December 23, 1982 based on Notaries Deed No.45 of Hobropoerwanto, SH. The Company’s articles of association has been amended several times, most recently by notarial deed No. 142 of Mr. Aulia Taufani, SH., dated Sep 24, 2007, concerning among others, the change Company’s capital structure and public offering.

Read more on JKON

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK